DoseMe Revenue and Competitors
Estimated Revenue & Valuation
- DoseMe's estimated annual revenue is currently $2.4M per year.
- DoseMe's estimated revenue per employee is $98,000
Employee Data
- DoseMe has 24 Employees.
- DoseMe grew their employee count by 4% last year.
DoseMe's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Strategy and Science Officer | Reveal Email/Phone |
2 | Chief Operations Officer | Reveal Email/Phone |
3 | Chief Compliance Officer | Reveal Email/Phone |
4 | President and CEO | Reveal Email/Phone |
DoseMe Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0M | 1142 | 7% | $186.6M | N/A |
#2 | $41.7M | 271 | N/A | N/A | N/A |
#3 | $12.6M | 90 | -18% | N/A | N/A |
#4 | $2.4M | 24 | 4% | N/A | N/A |
#5 | $6.9M | 55 | N/A | N/A | N/A |
#6 | $11.3M | 81 | 16% | N/A | N/A |
#7 | $0.4M | 6 | -45% | N/A | N/A |
#8 | $43M | 279 | 27% | N/A | N/A |
#9 | $30.4M | 202 | -13% | $87.1M | N/A |
#10 | $1.1M | 13 | N/A | N/A | N/A |
What Is DoseMe?
DoseMeRx is the world's first (and largest) Bayesian dosing platform. We combine smart technology with science, leveraging clinically-validated pharmacokinetic drug models, patient characteristics, drug concentrations and genotype to accurately individualize a dose in seconds. Spend less time on calculations - and more time on your patients.
keywords:N/AN/A
Total Funding
24
Number of Employees
$2.4M
Revenue (est)
4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
DoseMe News
2022-04-20 - Karaman'da tren yolu hatt?ndan dö?eme demiri çalan 4 ...
Karaman'da yap?m? devam eden h?zl? tren demiryolu hatt?ndan dö?eme demiri çalan 4 ?üpheli gözalt?na al?nd?. ... Karaman Jandarma ekipleri,...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $5.3M | 28 | -7% | N/A |
#2 | N/A | 28 | 4% | N/A |
#3 | $35M | 32 | -9% | N/A |
#4 | $7.4M | 32 | 3% | N/A |
#5 | $0M | 33 | -3% | N/A |